PODXL and colon carcinoma: The first study was conducted by perfusing E- and P-selectin-expressing Chinese Ovarian (CHO) cells and L-selectin-expressing human peripheral blood lymphocytes over purified PCLP1 protein derived from colon carcinoma cells and by cell-free flow-based adhesion assays using PCLP1-coated microspheres (78).